Ami Bhatt
Cardiovascular Disease · Boston, MANPI 1285600155
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $34,680 of the $36,869 with a category attached, or 94.1%. 10 manufacturers reported payments, led by AstraZeneca at 43.7% of the total. Reporting peaked in 2020 at $20,660 and has fallen 94.4% since, to $1,160 in 2025.
Across 15 payments — averaging $2457.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$16K
- E.r. Squibb & Sons, L.L.C.$14K
- Novartis$3K
- Actelion Pharmaceuticals, Ltd$2K
- GE HealthCare$1K
- Edwards Lifesciences$343
- plus $568 from 4 others
Across 46 payments — averaging $6891.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$317K
What the payments were for
- Consulting fees$34,68094%
- Speaking & faculty fees$1,1603%
- Travel & lodging$3431%
- Food & beverage$6852%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $16,110 |
| E.r. Squibb & Sons, L.L.C. | 4 | $14,350 |
| Novartis | 2 | $2,567 |
| Actelion Pharmaceuticals, Ltd | 1 | $1,770 |
| GE HealthCare | 1 | $1,160 |
| Edwards Lifesciences | 1 | $343 |
| Abbott | 2 | $214 |
| Boston Scientific | 1 | $154 |
| Aidoc Medical Ltd | 1 | $131 |
| Acarix USA Inc. | 1 | $69 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$4,550
- GENERAL - THERAPIES$154
- Briefcase$131
- LEQVIO$117
- DRAGONFLY OPSTAR$114
How this compares
$36,869 in reported general payments places this provider in the 85th percentile of 750 cardiovascular disease providers in Massachusetts.
Other cardiovascular disease in Boston
- Marc SabatineBoston$3.9M
- Elizabeth NabelBoston$2.2M
- Kenneth RosenfieldBoston$1.4M
- James JanuzziBoston$1.1M
- Muthiah VaduganathanBoston$972K
- Joseph LoscalzoBoston$926K
- Sunil KapurBoston$823K
- Paul ZeiBoston$786K
- Paul RidkerBoston$572K
- Ignacio Inglessis-AzuajeBoston$545K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.